For the full year 2022, Boiron posted a 17.4% increase in sales to 534.2 million euros, including growth of 13.6% at constant exchange rates (+9.4% in France and +26.1% internationally).

In detail, again at constant exchange rates, the 6.9% fall in sales of non-proprietary homeopathic medicines was more than offset by growth of 29.2% for homeopathic specialties and 28.2% for other healthcare products.

Given the significant change in sales over the year, the French homeopathic specialist expects its annual operating profit for the past year to be higher than that published in 2021.

Copyright (c) 2023 CercleFinance.com. All rights reserved.